CA3091955A1 - Use of an oral bolus in the drying-off of dairy cattle - Google Patents

Use of an oral bolus in the drying-off of dairy cattle Download PDF

Info

Publication number
CA3091955A1
CA3091955A1 CA3091955A CA3091955A CA3091955A1 CA 3091955 A1 CA3091955 A1 CA 3091955A1 CA 3091955 A CA3091955 A CA 3091955A CA 3091955 A CA3091955 A CA 3091955A CA 3091955 A1 CA3091955 A1 CA 3091955A1
Authority
CA
Canada
Prior art keywords
cattle
bolus
dry
oral
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3091955A
Other languages
English (en)
French (fr)
Inventor
Daniel Zaspel
Juergen BUBECK
Holger Enderle
Laurent GOBY
Leif Hoejvang-Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of CA3091955A1 publication Critical patent/CA3091955A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/24Compounds of alkaline earth metals, e.g. magnesium
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/02Ammonia; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/20Elemental chlorine; Inorganic compounds releasing chlorine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3091955A 2018-05-23 2019-05-20 Use of an oral bolus in the drying-off of dairy cattle Pending CA3091955A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18173742.0 2018-05-23
EP18173742 2018-05-23
PCT/EP2019/062958 WO2019224149A1 (en) 2018-05-23 2019-05-20 Use of an oral bolus in the drying-off of dairy cattle

Publications (1)

Publication Number Publication Date
CA3091955A1 true CA3091955A1 (en) 2019-11-28

Family

ID=62235859

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3091955A Pending CA3091955A1 (en) 2018-05-23 2019-05-20 Use of an oral bolus in the drying-off of dairy cattle

Country Status (13)

Country Link
US (2) US10966921B2 (https=)
EP (1) EP3668525A1 (https=)
JP (1) JP7154384B2 (https=)
KR (1) KR20210013202A (https=)
CN (1) CN112153972A (https=)
AU (1) AU2019272711B2 (https=)
BR (1) BR112020023845A2 (https=)
CA (1) CA3091955A1 (https=)
CL (1) CL2020002843A1 (https=)
EA (1) EA202092782A1 (https=)
MX (1) MX2020012468A (https=)
UA (1) UA129834C2 (https=)
WO (1) WO2019224149A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019224149A1 (en) * 2018-05-23 2019-11-28 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle
AR122366A1 (es) * 2020-01-27 2022-09-07 Ceva Sante Animale Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche
UY39022A (es) * 2020-01-27 2021-07-30 Ceva Sante Animale Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria
HUE067496T2 (hu) 2020-12-08 2024-10-28 Ruminant Biotech Corp Ltd Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360823A (en) 1993-11-02 1994-11-01 Dawe's Inc. Anionic salt formulation for milk fever
US5686125A (en) * 1995-10-31 1997-11-11 Kalmbach Feeds, Inc. Granular anionic dry cow product
EP0943246A1 (en) 1998-02-04 1999-09-22 Suomen Rehu Oy Complete fodder
US20020150633A1 (en) 1999-03-31 2002-10-17 Myron Danzer Dry dairy cow supplement
US6521249B2 (en) * 2001-03-22 2003-02-18 Church & Dwight Co., Inc. Feedstock for prepartum dairy cattle
US9497981B2 (en) 2012-06-28 2016-11-22 Phibro Animal Health Corporation Medicated particulate animal feed supplements and methods of preparation
CN105029016B (zh) * 2015-07-10 2019-03-15 石河子大学 围产前期奶牛专用糊化阴离子盐添加剂及其制备方法
AU2018212566B2 (en) * 2017-01-24 2022-11-24 OmniGen Research, L.L.C. Granulated feed supplement and methods for making and using
EP3764807A4 (en) * 2018-03-14 2021-11-03 Sustainable Community Development, LLC PROBIOTIC AND FOOD ADDITIVE COMPOSITION
WO2019224149A1 (en) * 2018-05-23 2019-11-28 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle
EP4064854A1 (en) 2019-11-28 2022-10-05 Boehringer Ingelheim Vetmedica GmbH Use of sglt-2 inhibitors in the drying-off of non-human mammals
US11723919B2 (en) 2020-06-12 2023-08-15 Phibro Animal Health Corporation Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D

Also Published As

Publication number Publication date
MX2020012468A (es) 2021-02-09
JP2021520417A (ja) 2021-08-19
US20190358154A1 (en) 2019-11-28
US20210177747A1 (en) 2021-06-17
JP7154384B2 (ja) 2022-10-17
US11890374B2 (en) 2024-02-06
KR20210013202A (ko) 2021-02-03
CL2020002843A1 (es) 2021-04-23
EP3668525A1 (en) 2020-06-24
BR112020023845A2 (pt) 2021-04-13
AU2019272711A1 (en) 2020-11-19
EA202092782A1 (ru) 2021-04-19
WO2019224149A1 (en) 2019-11-28
AU2019272711B2 (en) 2024-10-03
US10966921B2 (en) 2021-04-06
CN112153972A (zh) 2020-12-29
UA129834C2 (uk) 2025-08-20

Similar Documents

Publication Publication Date Title
US11890374B2 (en) Use of an oral bolus in the drying-off of dairy cattle
Goff Calcium and magnesium disorders
Apelo et al. Effects of reduced dietary protein and supplemental rumen-protected essential amino acids on the nitrogen efficiency of dairy cows
Piantoni et al. Evaluation of propylene glycol and glycerol infusions as treatments for ketosis in dairy cows
Khorasani et al. Influence of carbohydrate source and buffer on rumen fermentation characteristics, milk yield, and milk composition in late-lactation Holstein cows
Rogers et al. Production responses of dairy cows fed various amounts of rumen-protected methionine and lysine
JP7441946B2 (ja) 非ヒト動物の乾乳におけるsglt-2阻害剤の使用
Wu et al. Calcium homeostasis, acid–base balance, and health status in periparturient Holstein cows fed diets with low cation–anion difference
Aditya et al. Intramammary infusion of Escherichia coli lipopolysaccharide negatively affects feed intake, chewing, and clinical variables, but some effects are stronger in cows experiencing subacute rumen acidosis
Fleming et al. Assessing bioavailability of ruminally protected methionine and lysine prototypes
Maynou et al. Effects of oral administration of acidogenic boluses at dry-off on performance and behavior of dairy cattle
Goff Transition cow immune function and interaction with metabolic diseases
Imran et al. Effect of microencapsulated butyric acid supplementation on growth performance, ileal digestibility of protein, duodenal morphology and immunity in broilers
Giaccone et al. Factors associated with milk urea concentrations in Girgentana goats
Shen et al. Transfer efficiency of melamine from feed to milk in lactating dairy cows fed with different doses of melamine
Schwab et al. Methionine supplementation options
EA046153B1 (ru) Применение перорального болюса при запуске молочного рогатого скота
BR122024001079A2 (pt) Uso de um bolus oral e métodos relacionados
Olagaray et al. Relative bioavailability of carnitine delivered by ruminal or abomasal infusion or by encapsulation in dairy cattle
Bilgeçli et al. The effects of supplementation of milk with sodium butyrate on calf performance, some blood parameters and fecal Escherichia coli (E. coli) presence1
Goff Transition period management and nutrition problems-A few solutions
Wood et al. Effect of porcine plasma on growth and health of Holstein calves
Wells Using Plasma Amino Acid Profiles to Identify the Limiting Amino Acids in Lactating Dairy Cows
Mammi Strategies to improve transition dairy cows health and milk quality
Richards Assessing Bioavalability of Methionine Products and Their Effect on Milk Production and Body Composition

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230517

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20241024

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250203

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250512

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250512

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250527

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250527

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250820

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20251127